• Home
  • Study Details
By physician referral or invitation only

Clinical Evaluation of the Panbio™ COVID-19/​Flu A&B Panel

Collecting nasal swab samples from symptomatic subjects potentially infected with COVID19 or influenza. These samples will be used to compare diagnostic testing accuracy of the new Panbio device panel versus other comparative devices.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Eugenia Quackenbush
Emergency Medicine

Study Type

Clinical or Medical
Interventional

Study Topics

Healthy Volunteer or General Population
Immune System/Infections
COVID-19

IRB Number

23-2963

ClinicalTrials.gov

NCT06127108

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research